Nolan Sean P. is Chief Executive Officer of Taysha Gene Therapies Inc.
Person profile
Roles
Taysha Gene Therapies
Chief Executive Officer
Ventas
Director
Address
Brisbane, California
Employees
SEC CIK
Latest filings (excl ownership)
No filings
Latest ownership filings
4
Taysha Gene Therapies, Inc.
4 Jan 24
4
Taysha Gene Therapies, Inc.
18 Dec 23
4
Taysha Gene Therapies, Inc.
16 Aug 23
4
Ventas, Inc.
18 May 23
4
Taysha Gene Therapies, Inc.
4 Jan 23
4
Taysha Gene Therapies, Inc.
22 Jun 22
4
Ventas, Inc.
29 Apr 22
3
Social Capital Suvretta Holdings Corp. II
24 Sep 21
4
Taysha Gene Therapies, Inc.
21 Jun 21
4
Ventas, Inc.
27 May 21
Recent insider trades
Date | Company | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
2 Jan 24 | TSHA Taysha Gene Therapies | Common Stock | Grant | Acquire A | No | No | 0 | 1,184,688 | 0.00 | 1,185,858 |
2 Jan 24 | TSHA Taysha Gene Therapies | Employee Stock Option Common Stock | Grant | Acquire A | No | No | 1.71 | 1,184,688 | 2.03 mm | 1,184,688 |
14 Dec 23 | TSHA Taysha Gene Therapies | Employee Stock Option Common Stock | Grant | Acquire A | No | No | 0.6989 | 466,550 | 326.07 k | 466,550 |
16 Aug 23 | TSHA Taysha Gene Therapies | Common Stock | Buy | Acquire P | Yes | No | 0.9 | 444,444 | 400.00 k | 1,535,545 |
16 May 23 | VTR Ventas | Common Stock | Grant | Acquire A | No | No | 45.63 | 3,835 | 174.99 k | 17,604 |
30 Dec 22 | TSHA Taysha Gene Therapies | Stock Option Common Stock | Grant | Acquire A | No | No | 2.26 | 1,106,131 | 2.50 mm | 1,106,131 |